Cargando…

Implementation and evaluation of a pharmacist-run mental health treatment clinic via clinical video telehealth

INTRODUCTION: The Veterans Health Administration is extending its mental health services to reach those in rural areas who find it difficult to travel to a Veterans Affairs Medical Center (VAMC). This project aimed to outline implementation of a Pharmacy Mental Health Clinical Video Telehealth (MHCV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leach, Molly, Garcia, Guadalupe, Ganzer, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2016
Materias:	Open Submissions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007644/ https://www.ncbi.nlm.nih.gov/pubmed/29955464 http://dx.doi.org/10.9740/mhc.2016.05.159

Ejemplares similares

A consumer-led intervention to improve pharmacists' attitudes toward mental illness
por: Rickles, Nathaniel M., et al.
Publicado: (2016)

Quantitative and economic analysis of clinical pharmacist interventions during rounds in an acute care psychiatric hospital
por: Gunterus, Alicia, et al.
Publicado: (2016)

Evaluation of provider response to positive depression screenings and physician attitudes on integrating psychiatric pharmacist services in primary care settings
por: Denson, Brittany H., et al.
Publicado: (2018)

Evaluation of clinical pharmacy services within the primary care–mental health integration model at the Tuscaloosa Veterans Affairs Medical Center
por: Parikh, Mamta, et al.
Publicado: (2016)

A pilot study evaluating the effectiveness of a medicines education group in a mental health inpatient setting: A UK perspective
por: White, Daniel, et al.
Publicado: (2018)

Using Photovoice to explore patients' experiences with mental health medication: A pilot study
por: Werremeyer, Amy B., et al.
Publicado: (2016)

A design and focus group evaluation of dietary choices tools for an underserved population
por: McMorris, Tressa, et al.
Publicado: (2016)

Evaluation of the use of low-dose quetiapine and the risk of metabolic consequences: A retrospective review
por: Carr, Chelsea N., et al.
Publicado: (2016)

Evaluation of adherence in patients prescribed long-acting injectable antipsychotics: A comparison of biweekly versus monthly administered neuroleptics
por: Carr, Chelsea N., et al.
Publicado: (2016)

Diuretics: A possible keystone in upholding cognitive health
por: DeLoach, Tyler, et al.
Publicado: (2018)

Outcomes of patient education practices to optimize the safe use of lithium: A literature review
por: Zolezzi, Monica, et al.
Publicado: (2018)

Mania possibly linked with bupropion for smoking cessation: A case report
por: Dwyer, Stephanie, et al.
Publicado: (2016)

Identification, assessment, and management of pain in patients with advanced dementia
por: Malotte, Kasey L., et al.
Publicado: (2016)

Suicide prevention in pharmaceutical education: Raising awareness with inspiring stories
por: Vincent, Philippe D., et al.
Publicado: (2016)

Impact on length of stay and readmission rates when converting oral to long-acting injectable antipsychotics in schizophrenia or schizoaffective disorder
por: Chou, Fabienne, et al.
Publicado: (2016)

Hospitalizations and emergency room visits after initiation of long-acting injectable antipsychotics
por: Heesch, Chelsie B., et al.
Publicado: (2016)

Management of migraine headaches in a chronic pain patient: A case report
por: Bach, Linda Lu, et al.
Publicado: (2016)

Implementation and evaluation of Parkinson disease management in an outpatient clinical pharmacist–run neurology telephone clinic
por: Stefan, Teodora Cristina, et al.
Publicado: (2018)

Evaluating the clinical utility of the patient‐identified most bothersome symptom measure from PROMISE‐2 for research in migraine prevention
por: Lipton, Richard B., et al.
Publicado: (2022)

American Association for the Surgery of Trauma/American College of Surgeons Committee on Trauma clinical protocol for management of acute respiratory distress syndrome and severe hypoxemia
por: Fawley, Jason A., et al.
Publicado: (2023)

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine
por: Ford, Janet H., et al.
Publicado: (2020)

Risk of hypertension in erenumab‐treated patients with migraine: Analyses of clinical trial and postmarketing data
por: Dodick, David W., et al.
Publicado: (2021)

In patients with combined clavicle and multiple rib fractures, does fracture fixation of the clavicle improve clinical outcomes? A multicenter prospective cohort study of 232 patients
por: Hoepelman, Ruben J., et al.
Publicado: (2023)

Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data
por: Choong, Casey K., et al.
Publicado: (2017)

Characteristics of migraine in patients with headache disorders: A clinic‐based study from Central American and Caribbean countries
por: Monterrey, Priscilla, et al.
Publicado: (2022)

ATLAS and CMS physics results from Run 2
por: Nellist, Clara
Publicado: (2015)

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan
por: Kudrow, David, et al.
Publicado: (2020)

A Close Look at the Clinical Efficacy of Rho-Associated Protein Kinase Inhibitor Eye Drops for Fuchs Endothelial Corneal Dystrophy
por: Kinoshita, Shigeru, et al.
Publicado: (2021)

Start of run2 physics at the Large Hadron Collider (LHC)
por: Brice, Maximilien
Publicado: (2015)

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post‐Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial
por: Dodick, David W., et al.
Publicado: (2018)

Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo‐controlled randomized clinical trials
por: Schim, Jack D., et al.
Publicado: (2022)

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies
por: Ashina, Messoud, et al.
Publicado: (2019)

A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist
por: Kudrow, David, et al.
Publicado: (2022)

AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks
por: Tepper, Stewart J, et al.
Publicado: (2015)

Heavy Ion Run 3 stable beams seen from ATLAS Control Room
por: Pham, Joni
Publicado: (2023)

Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ)
por: Kawata, Ariane K., et al.
Publicado: (2019)

Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans
por: Jakate, Abhijeet, et al.
Publicado: (2020)

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)

A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine
por: Winner, Paul K., et al.
Publicado: (2020)

Evaluation of the 6‐item Identify Chronic Migraine screener in a large medical group
por: Pavlovic, Jelena M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rlqfcu6nkle72ddbh0ect943g5